Cargando…

Implications of COVID-19 vaccine boosters amid the emergence of novel variants of SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Dhawan, Manish, Emran, Talha Bin, Choudhary, Om Prakash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001012/ https://www.ncbi.nlm.nih.gov/pubmed/35432993 http://dx.doi.org/10.1016/j.amsu.2022.103612

Ejemplares similares

Vaccine inequity and hesitancy: Dual factors in the emergence of novel SARS-CoV-2 variants
por: Dhawan, Manish, et al.
Publicado: (2021)

Emergence of Omicron sub-variant BA.2: Is it a matter of concern amid the COVID-19 pandemic?
por: Dhawan, Manish, et al.
Publicado: (2022)

SARS-CoV-2 and Influenza A virus: Dual diagnostics and vaccines
por: Saied, AbdulRahman A., et al.
Publicado: (2022)

A rapid surge of the Omicron variant’s sublineages BQ.1/BQ.1.1: A matter of worry amid the crucial trajectory of the COVID-19 pandemic
por: Dhawan, Manish, et al.
Publicado: (2023)

Emergence of omicron variant's sublineages BA.4 and BA.5: risks assessment and possible countermeasures
por: Dhawan, Manish, et al.
Publicado: (2022)

Russo-Ukrainian war amid the COVID-19 pandemic: Global impact and containment strategy
por: Dhawan, Manish, et al.
Publicado: (2022)

Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt
por: Dhawan, Manish, et al.
Publicado: (2022)

Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions
por: Islam, Fahadul, et al.
Publicado: (2022)

Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
por: Dhawan, Manish, et al.
Publicado: (2022)

Florona: An emerging threat posing alarming risks to global public health and possible containment measures
por: Islam, Fahadul, et al.
Publicado: (2022)

Immunomodulatory effects of zinc and its impact on COVID-19 severity
por: Dhawan, Manish, et al.
Publicado: (2022)

Convalescent plasma therapy against the emerging SARS-CoV-2 variants: Delineation of the potentialities and risks
por: Dhawan, Manish, et al.
Publicado: (2022)

Evolution of SARS-CoV-2: A prediction on the lineages and vaccine effectiveness
por: Priyanka, et al.
Publicado: (2021)

Three dimensional printed wound dressings: recent progresses
por: Chopra, Hitesh, et al.
Publicado: (2023)

Microneedles for ophthalmic drug delivery: recent developments
por: Chopra, Hitesh, et al.
Publicado: (2023)

Omicron variant (B.1.1.529) of SARS-CoV-2: Threat assessment and plan of action
por: Choudhary, Om Prakash, et al.
Publicado: (2022)

Antiviral pills: A potential game-changing therapy against COVID-19
por: Dhawan, Manish, et al.
Publicado: (2022)

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

Role of natural products towards the SARS-CoV-2: A critical review
por: Raman, Kannan, et al.
Publicado: (2022)

SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects – correspondence
por: Channabasappa, Nikhil K., et al.
Publicado: (2023)

NeoCoV: A foresight of the next possible pandemic
por: Dhawan, Manish, et al.
Publicado: (2022)

Recent outbreak of monkeypox: Overview of signs, symptoms, preventive measures, and guideline for supportive management
por: Shuvo, Pollob Ahmed, et al.
Publicado: (2022)

Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
por: Yu, Xiaoqi, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic
por: Tareq, Abu Montakim, et al.
Publicado: (2021)

Aerosol transmission of SARS-CoV-2: The unresolved paradox
por: Priyanka, et al.
Publicado: (2020)

Comparative overview of emerging RNA viruses: Epidemiology, pathogenesis, diagnosis and current treatment
por: Chakrabartty, Ishani, et al.
Publicado: (2022)

MERS-CoV recently re-emerged in Qatar, Saudi Arabia, its feasible global health risks amid FIFA world cup 2022 and salient counteracting strategies – an update
por: Chopra, Hitesh, et al.
Publicado: (2023)

Airport smoking zones: a prospective public health hazard
por: Singh, Ravinder, et al.
Publicado: (2023)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
por: Sharun, Khan, et al.
Publicado: (2021)

Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
por: Dhawan, Manish, et al.
Publicado: (2022)

A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice
por: Zhang, Rong, et al.
Publicado: (2022)

Will the next spillover pandemic be deadlier than the COVID-19?: A wake-up call
por: Choudhary, Om Prakash, et al.
Publicado: (2022)

Emergence of monkeypox: Risk assessment and containment measures
por: Dhawan, Manish, et al.
Publicado: (2022)

Immunomodulatory and therapeutic implications of vitamin D in the management of COVID-19
por: Dhawan, Manish, et al.
Publicado: (2022)

Unusual spread of the monkeypox virus: An emerging threat to the public health and the possible containment
por: Islam, Fahadul, et al.
Publicado: (2022)

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
por: Abdool Karim, Salim S., et al.
Publicado: (2021)

Vaccine efficacy against COVID-19: A foresight on the host-associated factors
por: Priyanka, et al.
Publicado: (2021)

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
por: Kuhlmann, Constanze, et al.
Publicado: (2022)

Monkeypox from Congo 1970 to Europe 2022; is there a difference?
por: Khaity, Abdulrhman, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0bk63eqma2d2ia7k21tl4q1f6k